Compare Progressive Corp (PGR) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Progressive Corp vs Revolution Medicines Inc. Common Stock — how do they compare? Progressive Corp trades at $219.06 (market cap $126.95B), while Revolution Medicines Inc. Common Stock trades at $187.97 (market cap $40.32B). The key difference: Progressive Corp is far larger — about 3.1× Revolution Medicines Inc. Common Stock's market cap, and Progressive Corp pays a 0.18% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Progressive Corp for 81 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| PGR | RVMD | |
|---|---|---|
Market Cap | $126.95B | $40.32B |
Volume | 2,749,438 | 4,855,734 |
Sector | Financials | Health |
52-Week High | $242.16 | $221.15 |
52-Week Low | $190.40 | $47.50 |
Typical Hold Time | 81 Days | 0 Days |
Enterprise Value | $135.16B | $37.02B |
Dividend Yield | 0.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Progressive Corporation (PGR) trades at $214.12, up 0.98% with a bullish technical outlook supported by moving averages. The company demonstrates strong fundamentals with revenue growth from $49.6B in 2022 to $87.6B in 2025 and robust profitability metrics including 34.94% ROE. Recent earnings show mixed results with Q2 2026 beating expectations while Q1 2026 missed. Analyst consensus leans neutral with 52.38% hold ratings but a $222.23 price target suggests modest upside potential from current levels.
PGR presents a balanced investment case with solid fundamentals and reasonable valuation (P/E 10.97) offset by competitive pressures in personal auto insurance. The stock's technical strength and consistent revenue growth support potential upside, though investors should monitor underwriting discipline amid intensifying market competition. Key risks include execution challenges and macroeconomic sensitivity affecting insurance demand.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Progressive Corp
Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →
